Back to search results

Virtual Reality for Sedation During Endoscopy

This study is testing if using a Pico 4 Enterprise virtual reality (VR) headset during endoscopy procedures can help reduce the amount of sedative drugs needed. You might be eligible if you are between 21 and 65 years old and are having a screening colonoscopy or a diagnostic upper endoscopy for GERD (Gastroesophageal Reflux Disease) or dyspepsia at NYU Langone Brooklyn Hospital. The study aims to see if VR can decrease the total amount of sedative drugs like Versed and Fentanyl administered, improve your satisfaction, and shorten recovery time. This is a small pilot study with 10 planned participants, and its current status is unclear.

Study design
This is a prospective pilot study with 10 participants. All participants will receive minimal sedation and wear VR goggles during their procedure.
What's involved
You would undergo a screening colonoscopy or diagnostic upper endoscopy. You would wear VR goggles during the procedure.
Compensation
Not stated in the trial record.
Follow-up
The total amount of sedative drugs will be measured at the end of the procedure, up to 1 hour.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06349564

Implementing Virtual Reality (VR) to Reduce Sedation

Recruiting
NAAges 21–65InterventionalSupportive care
NYU Langone Health
~10 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:Pico 4 Enterprise headset with noise cancelling headphones

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Total amount of sedative drugs administered during the procedure
Measured over End of procedure, up to 1 hour

Conditions

Sedative During Endoscopy

Explore related trials

ColonoscopyDyspepsiaGastroesophageal Reflux DiseaseUpper Endoscopy

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Maysaa El Zoghbi, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

Maysaa El Zoghbi, MD
[email protected]
216-835-7626
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
Aged 21 to 65
Underwent screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
Aged 21 to 65

Exclusion

Visual impairments such as blindness which would impair them from watching the entertainment videos.
Patients with history of CAD,
History of seizures,
History of vertigo,
History of allergy to plastic,
ASAII or III,
Patient with active GI bleed, having either melena or hematochezia.
Visual impairments such as blindness which would impair them from watching the entertainment videos
Patients with history of CAD
History of seizures
History of vertigo
History of allergy to plastic
ASAII or III
Patient with active GI bleed, having either melena or hematochezia

What this trial measures

  • Total amount of sedative drugs administered during the procedureEnd of procedure, up to 1 hour